Plover Bay Technologies Stock (OTC: PBTDF)

Latest news for Plover Bay Technologies (OTC:PBTDF) Stock

Plover Bay Technologies Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the research, design, development, and marketing of Software Defined WAN (SD-WAN) routers and the provision of software licenses and warranty and support services. The Company's products and services are used by enterprise users, such as multinational companies, as well as industry users. The SD-WAN routers segment mainly offers wired and wireless routers bundled together with embedded software and firmware. The Company mainly operates its business in Hong Kong, Taiwan, the United States of America, Malaysia, Canada, Mexico, the United Kingdom, Singapore, France, as well as Israel, among others.

PLOVER BAY TECHN LTD by PLOVER BAY TECHNOLOGIES LTD.

Plover Bay Technologies Ltd

News

Downgrades

Analyst Ratings

Moody's Downgrades Alaska Air Group's Issuer Rating To Ba1, Assigns Baa2 Rating To Loyalty Financing; Outlook Negative

Management

IAM Workers Existing Contract With Textron Expired Sept. 22

Genius Group Receives Allegations From LZG International Shareholders; Terminates Peter Ritz, Investigates Ownership And Control Issues With Michael Moe And Peter Ritz Through Counsel

WIIM

GOLD

RGLD

SAND

SSRM

Shares of gold companies are trading higher after the price of the commodity reached all-time highs following last week's Fed rate cut.

Macro Economic Events

Economics

Gold is trading higher following the Fed's recent rate cut.

<a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/novavax.html" title="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/novavax.html">https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/novavax.html</a>

NVAX

Reported September 23; Health Canada Approves Novavax Nuvaxovid And XBB.1.5 Omicron Subvariant COVID-19 Vaccines For Primary And Booster Doses

On Tuesday, artificial intelligence server company Super Micro Computer, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) added new maximum-performance GPU, multi-node, and rackmount systems to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/n41007202/supermicro-adds-new-max-performance-intel-based-x14-servers-delivering-the-industrys-broadest-rang" rel="noreferrer noopener">the X14 portfolio</a>.
These systems are based on Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) Xeon 6900 Series Processors with P-Cores (formerly codenamed Granite Rapids-AP).
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24121828/newplot-20.png" alt="" class="wp-image-563711" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24121828/newplot-20.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24121828/newplot-20-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Joining the X14 servers leveraging the Xeon 6700 Series Processors with E-cores launched in&nbsp;June 2024, today&#8217;s additions aim to create the industry&#8217;s broadest range of optimized servers supporting a wide variety of workloads from demanding AI, HPC, media, and virtualization to energy-efficient edge, scale-out cloud-native, and microservices applications.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/40897994/whats-going-on-with-intel-stock-on-tuesday" rel="noreferrer noopener">Intel Secures Major Amazon Chip Deal, U.S. Grant Amid Restructuring Plans</a>
&#8220;Supermicro X14 systems have been completely re-engineered to support the latest technologies including next-generation CPUs, GPUs, highest bandwidth and lowest latency with MRDIMMs, PCIe 5.0, and EDSFF E1.S and E3.S storage,&#8221; said&nbsp;Charles Liang, president and CEO of Supermicro.
Supermicro&#8217;s new X14 systems will also offer socket compatibility with the upcoming Intel Xeon 6900 series processors with E-cores and Intel Xeon 6700 series processors with P-cores.
Last week, Needham&nbsp;analyst Quinn Bolton hailed Super Micro as a <a target="_blank" href="https://www.benzinga.com/news/24/09/40926422/super-micro-poised-for-expansion-as-gross-margin-concerns-ease-internal-control-risks-priced-in-anal" rel="noreferrer noopener">significant beneficiary of</a> growing investment in AI infrastructure, a first mover in rack-level liquid cooling solutions. He forecasted a revenue CAGR of over 55% from fiscal 2021 to fiscal 2026.
Super Micro Computer stock is up over 89% in the last 12 months. Bolton expects most of the risk associated with the review of its internal controls as priced in. Investors can gain exposure to the AI server company through Vanguard Mid-Cap Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOT#NYSE">VOT</a>) and SPDR Select Sector Fund &#8211; Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>).
Price Action:&nbsp;SMCI stock is down 0.25% at $464.77 at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40996401/intel-which-cratered-around-77-from-its-52-week-peak-finds-a-new-knight-in-shining-armor-as-qual" target="_blank" rel="noreferrer noopener">Intel, Which Cratered Around 77% From Its 52-Week Peak, Finds A New Knight In Shining Armor As Qualcomm And Apollo Propose Buyout Deal, But This Analyst Thinks It Doesn&#8217;t Make Sense: &#8216;It Seems Very Risky To Us Given Uncertain Returns&#8217;</a></li>
</ul>
Photo via Company

INTC

SMCI

Super Micro Unveils Next-Gen Servers Powered by Intel's Latest Xeon Chips

Particle Health Inc. <a href="https://fingfx.thomsonreuters.com/gfx/legaldocs/akveodjmyvr/particle%20v%20epic%20-%20complaint%20-%2020240923.pdf" target="_blank" rel="noreferrer noopener">sued</a> Epic Systems Corporation, alleging that the software firm is attempting to use its power over electronic health records (EHRs) to expand its dominance into the fledgling <a href="https://www.benzinga.com/topic/software">market for &#8220;payer platforms.&#8221;</a>
Epic&#8217;s EHR system controls over three-quarters of U.S. patient records. The company has leveraged its vast market power to extend its influence into the emerging payer platform market.
In 2021, Epic launched the Epic Payer Platform (EPP), which quickly gained market dominance. The lawsuit claims that competitors could not gain ground.
Epic allegedly made it commercially impossible for rival platforms to access medical records stored in its EHR system.
As a result, competing platforms could not function effectively.
A turning point came in 2023 when Particle Health entered the market by leveraging a shift in payer operations.
Particle found a way to access medical records through centralized exchange networks, offering an alternative to Epic&#8217;s monopoly. 
Epic allegedly cut off access to records for Particle&#8217;s customers, coercing them into ending their relationships with Particle and deliberately slowing down the approval process for new clients.
Epic&#8217;s efforts extended further, with allegations that it made false claims about the security and privacy risks associated with Particle. 
Particle says the claims damaged its credibility and hindered its ability to secure new business.
Epic also initiated a formal dispute with Particle through Carequality, a nonprofit overseeing data-sharing frameworks in healthcare.
The drawn-out dispute process and denial of record access have reportedly drained Particle&#8217;s resources, severely limiting its capacity to compete.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41010971/kbr-lands-113m-air-force-deal-to-drive-next-gen-refueling-systems-and-cybersecurity-innovation" target="_blank" rel="noreferrer noopener">KBR Lands $113M Air Force Deal To Drive Next-Gen Refueling Systems And Cybersecurity Innovation</a>.</li>
</ul>

Health Care

Tech

Healthcare Software Giant Epic Systems Hit With Lawsuit Over Alleged Monopolistic Practices

Shares of credit card and payment stocks are trading lower. The sector may be under pressure. Some payments stocks may also be down after Global Payments issued soft guidance.

Better pricing, prudent underwriting, increased exposure and faster economic recovery should help Multiline insurers to grow. The industry has returned 17.7% year to date compared with the Finance sector&#39;s growth of 15.3%. The Zacks S&amp;P 500 composite has witnessed an increase of 19.6% in the said time frame. Product diversification helps insurance industry players lower concentration risk and improve retention ratio.
<h2>YTD Performance</h2>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4a/78960.jpg?v=1188445588" /> 
Image Source: Zacks Investment Research
Accelerated digitalization will help the industry function smoothly. An improving rate environment should drive investment income higher as insurers are beneficiaries of a better rate environment.
Here we focus on two multiline insurers, namely Assurant, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aiz#NYSE">AIZ</a>) and Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>).
Assurant, with a market capitalization of $10.26 billion, provides business services that support, protect and connect consumer purchases in North America, Latin America, Europe and the Asia Pacific. Old Republic International, with a market capitalization of $9.21 billion, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. AIZ and ORI carry a Zacks Rank #2 (Buy) each at present.
Multiline insurers benefit from a diversified portfolio that lowers concentration risk. While higher demand for protection products benefits sales and premiums of life insurance operations, better pricing and increased exposure to intangibles and cyber threats support premium growth of non-life insurance operations.
Also, per Deloitte Insights, the transition to green energy and related insurance products, as well as exposure to intangible assets, offers growth opportunities. Per a report in Carrier Management, AM Best expects profitable commercial lines and improving personal lines in 2024. Swiss Re estimates high single-digit premium growth in 2024.
Insurers are direct beneficiaries of a rising rate environment. They invest a portion of their premiums. Long-tail insurers tend to gain more from rising rates as they have more time to invest their premiums and earn a higher rate of return. With a lower rate of return, investment income will suffer. In the FOMC meeting, the Federal Reserve announced cutting the interest rate by 50 basis points. This is the first time in four years that the central bank has taken such an action. The interest rate is now 4.75-5%, down from a more than two-decade high of 5.25-5.5%.
Multiline insurers are investing heavily in technology to improve scale and efficiencies. This should help them generate higher margins and improve profitability.
These positives together help insurers build solid policyholders&#39; surplus that helps the industry absorb losses. The solid capital level of the multiline insurers will fuel merger and acquisition activities to ramp up growth and aid these insurers to engage in shareholder-friendly moves.
Let&#39;s delve deeper into specific parameters to ascertain which multi-line insurer is better-positioned at the moment.
<h2>Price Performance&nbsp;&nbsp;&nbsp;</h2>
Shares of Old Republic have climbed 21.3% year to date, outperforming the industry&#39;s growth of 17.8% and Assurant&#39;s rise of 17.6%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d6/78959.jpg?v=326935590" />
Image Source: Zacks Investment Research
<h2>Return on Equity (ROE)&nbsp;&nbsp;&nbsp;</h2>
Assurant, with a ROE of 19.6%, exceeds Old Republic&#39;s ROE of 12.5% and the industry average of 16%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e8/78961.jpg?v=1855237749" />
Image Source: Zacks Investment Research
<h2>Debt-to-Capital&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h2>
Old Republic&#39;s debt-to-capital ratio of 24.8 is lower than the industry average of 31.8 and Assurant&#39;s reading of 29.3. Therefore, ORI has an advantage over AIZ on this front.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/6f/78962.jpg?v=2084482599" />
Image Source: Zacks Investment Research
<h2>Earnings Surprise History&nbsp;&nbsp;&nbsp;&nbsp;</h2>
AIZ outpaced expectations in each of the last seven reported quarters. ORI surpassed estimates in six of the last seven reported quarters.
<h2>Dividend Yield&nbsp;&nbsp;&nbsp;</h2>
Old Republic&#39;s dividend yield of 2.97% is better than Assurant&#39;s dividend yield of 1.45%. Thus, ORI has an advantage over AIZ on this front.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/83/78963.jpg?v=19303610" />
Image Source: Zacks Investment Research
<h2>Valuation&nbsp;&nbsp;&nbsp;&nbsp;</h2>
The price-to-book value is the best multiple used for valuing insurers. Compared with Assurant&#39;s P/B ratio of 2.06, Old Republic is cheaper, with a reading of 1.53. The multi-line insurance industry&#39;s P/B ratio is 2.70.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/3b/78965.jpg?v=499426243" />
Image Source: Zacks Investment Research
<h2>Growth Projection&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h2>
The Zacks Consensus Estimate for 2024 earnings indicates 7.6% growth from the year-ago reported figure for Old Republic, while the same for Assurant implies an increase of 6.7%.
<h2>Earnings Estimates&nbsp;&nbsp;&nbsp;&nbsp;</h2>
For 2024, the Zacks Consensus Estimate for AIZ has moved 2.9% north to $16.54 in the past 60 days, while the same for ORI has been revised 4.4% north to $2.83. Therefore, AIZ is in an advantageous position over ORI on this front.
<h2>Net Margin&nbsp;&nbsp;</h2>
Old Republic&#39;s net margin for the trailing 12 months was 8.59%, higher than Assurant&#39;s reading of 6.9%.
<h2>To Conclude</h2>
Our comparative analysis shows that Old Republic is better positioned than Assurant with respect to price, valuation, growth projection, dividend yield, leverage and net margin. AIZ outpaces ORI in terms of return on equity, earnings estimates and earnings surprise history. With the scale majorly tilted toward Old Republic, the stock appears to be better poised.
<a href="https://www.zacks.com/stock/news/2340682/assurant-or-old-republic-which-multiline-insurer-has-an-edge?cid=CS-BENZ-FT-analyst_blog|comparison_of_stocks-2340682">To read this article on Zacks.com click here.</a>

Asia

Earnings

Earnings Beats

Large Cap

Latin America

Mid Cap

Dividends

Federal Reserve

Markets

Trading Ideas

Insurance

Assurant or Old Republic: Which Multiline Insurer Has an Edge?

Investors with a lot of money to spend have taken a bullish stance on NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NEE, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 29 options trades for NextEra Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 65% bullish and 20%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $258,382, and 28, calls, for a total amount of $6,361,803.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $92.5 for NextEra Energy over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for NextEra Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across NextEra Energy's significant trades, within a strike price range of $55.0 to $92.5, over the past month.
<h3>NextEra Energy Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727202655_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$3.2</td>
<td>$3.1</td>
<td>$3.15</td>
<td>$90.00</td>
<td>$724.5K</td>
<td>1.9K</td>
<td>2.3K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$31.35</td>
<td>$30.65</td>
<td>$30.65</td>
<td>$55.00</td>
<td>$634.4K</td>
<td>3.0K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$31.15</td>
<td>$30.55</td>
<td>$30.55</td>
<td>$55.00</td>
<td>$623.2K</td>
<td>3.0K</td>
<td>2.2K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$31.5</td>
<td>$30.55</td>
<td>$30.55</td>
<td>$55.00</td>
<td>$604.9K</td>
<td>3.0K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$30.7</td>
<td>$30.65</td>
<td>$30.65</td>
<td>$55.00</td>
<td>$588.4K</td>
<td>3.0K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About NextEra Energy</h3>
NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to nearly 6 million customer accounts in Florida and owns 34 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 34 GW of generation capacity, including natural gas, nuclear, wind, and solar.
After a thorough review of the options trading surrounding NextEra Energy, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of NextEra Energy</h3>
<ul>
<li>Currently trading with a volume of 4,361,135, the NEE's price is down by -0.54%, now at $84.36. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<h3>What Analysts Are Saying About NextEra Energy</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $90.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on NextEra Energy, which currently sits at a price target of $102. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for NextEra Energy, targeting a price of $81. 
&#x2A; In a cautious move, an analyst from Jefferies downgraded its rating to Hold, setting a price target of $87. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NextEra Energy options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

NextEra Energy Unusual Options Activity For September 24

Deep-pocketed investors have adopted a bullish approach towards GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for GE Aero. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 53% leaning bullish and 23% bearish. Among these notable options, 3 are puts, totaling $133,600, and 10 are calls, amounting to $1,385,938.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $220.0 for GE Aero over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for GE Aero's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GE Aero's whale trades within a strike price range from $75.0 to $220.0 in the last 30 days. 
<h3>GE Aero Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727202650_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$8.15</td>
<td>$8.1</td>
<td>$8.15</td>
<td>$195.00</td>
<td>$448.2K</td>
<td>1.5K</td>
<td style="text-align: right;">552</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$8.35</td>
<td>$8.05</td>
<td>$8.15</td>
<td>$195.00</td>
<td>$261.7K</td>
<td>1.5K</td>
<td style="text-align: right;">873</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$11.3</td>
<td>$10.85</td>
<td>$11.25</td>
<td>$190.00</td>
<td>$210.3K</td>
<td>495</td>
<td style="text-align: right;">225</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.05</td>
<td>$8.0</td>
<td>$8.05</td>
<td>$195.00</td>
<td>$185.9K</td>
<td>1.5K</td>
<td style="text-align: right;">873</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$116.4</td>
<td>$114.35</td>
<td>$115.38</td>
<td>$75.00</td>
<td>$57.6K</td>
<td>12</td>
<td style="text-align: right;">5</td>
</tr>
</tbody>
</table>

<h3>About GE Aero</h3>
GE Aerospace is the global leader in designing, manufacturing, and servicing large aircraft engines, along with partner Safran in their CFM joint venture. With its massive global installed base of nearly 70,000 commercial and military engines, GE Aerospace earns most of its profits on recurring service revenue of that equipment, which operates for decades. GE Aerospace is the remaining core business of the company formed in 1892 with historical ties to American inventor Thomas Edison; that company became a storied conglomerate with peak revenue of $130 billion in 2000. GE spun off its appliance, finance, healthcare, and wind and power businesses between 2016 and 2024.
After a thorough review of the options trading surrounding GE Aero, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>GE Aero's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,987,352, the price of GE is up by 0.07%, reaching $188.81.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 28 days from now.</li>
</ul>
<h3>What Analysts Are Saying About GE Aero</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $206.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Deutsche Bank persists with their Buy rating on GE Aero, maintaining a target price of $212. 
&#x2A; Reflecting concerns, an analyst from Bernstein lowers its rating to Outperform with a new price target of $201.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest GE Aero options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

GE Aero's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie.
Looking at options history for AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $199,317 and 13, calls, for a total amount of $651,450.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $165.0 to $210.0 for AbbVie during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of AbbVie stands at 941.86, with a total volume reaching 2,530.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AbbVie, situated within the strike price corridor from $165.0 to $210.0, throughout the last 30 days.
<h3>AbbVie 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727202645_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$12.2</td>
<td>$12.0</td>
<td>$11.98</td>
<td>$195.00</td>
<td>$150.3K</td>
<td>559</td>
<td style="text-align: right;">291</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$9.2</td>
<td>$9.15</td>
<td>$9.18</td>
<td>$200.00</td>
<td>$108.8K</td>
<td>1.5K</td>
<td style="text-align: right;">237</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.73</td>
<td>$2.7</td>
<td>$2.73</td>
<td>$210.00</td>
<td>$96.7K</td>
<td>354</td>
<td style="text-align: right;">377</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$13.06</td>
<td>$185.00</td>
<td>$84.7K</td>
<td>3.1K</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$25.9</td>
<td>$25.5</td>
<td>$25.5</td>
<td>$170.00</td>
<td>$66.3K</td>
<td>550</td>
<td style="text-align: right;">36</td>
</tr>
</tbody>
</table>

<h3>About AbbVie</h3>
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
<h3>Where Is AbbVie Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,696,972, the price of ABBV is down by -0.11%, reaching $193.61.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 31 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

ABBV

Behind the Scenes of AbbVie's Latest Options Trends

TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) has outperformed the market over the past 5 years by 32.26% on an annualized basis producing an average annual return of 46.22%. Currently, TransMedics Gr has a market capitalization of $5.40 billion. 
Buying $100 In TMDX: If an investor had bought $100 of TMDX stock 5 years ago, it would be worth $670.09 today based on a price of $162.00 for TMDX at the time of writing.
<h3>TransMedics Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727202615_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TMDX

Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years

Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has outperformed the market over the past 20 years by 6.08% on an annualized basis producing an average annual return of 14.48%. Currently, Eli Lilly has a market capitalization of $827.14 billion. 
Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 20 years ago, it would be worth $15,297.50 today based on a price of $918.62 for LLY at the time of writing.
<h3>Eli Lilly's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727202610_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today

Rep. Maxine Waters (D-CA), the top Democrat on the House Financial Services Committee, is pushing for a &#8220;grand bargain&#8221; on stablecoin legislation before the end of the year, aiming to resolve two years of debates in Washington over the <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40946534/stablecoins-like-tether-becoming-systemically-important-bernstein">regulatory framework for stablecoins</a>.
What Happened: Waters, alongside Rep. Patrick McHenry (R-N.C.), the Republican chair of the committee, has been working since 2022 on legislation that would establish clear guidelines for stablecoin issuance and regulation, The Block <a href="https://www.theblock.co/post/317899/rep-maxine-waters-calls-for-grand-bargain-on-stablecoins-before-the-end-of-2024-following-years-of-negotiations?utm_source=twitter&amp;utm_medium=social">reported</a>.
While the bill advanced out of the Republican-led committee last year, it has struggled to gain broader support. 
Waters previously described the bill as &#8220;deeply problematic&#8221; due to a provision that allows state regulators to approve stablecoin issuances without involvement from the Federal Reserve.
During a House Financial Services Committee hearing on Tuesday, Waters expressed her optimism about reaching an agreement that balances consumer protection with federal oversight. 
"Mr. Chairman, before the end of this year, I want us to strike a grand bargain on stablecoins and other long overdue bills,&#8221; Waters said, noting that both sides have made significant concessions in the negotiation process.
She emphasized that the legislation must ensure that stablecoins are backed by secure reserves, such as short-term Treasury bills, to ensure their stability. 
&#8220;The Federal Reserve needs to have a dominant role,&#8221; Waters added, stressing the importance of federal involvement similar to other countries&#8217; approaches.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41008797/core-emerges-as-leading-bitcoin-sidechain-by-total-value-locked">Core Emerges As Leading Bitcoin Sidechain By Total Value Locked</a>
Waters also extended a challenge to her Republican colleague, saying, "I've made a public statement to you about bipartisanship — let's see what you do with it."
McHenry, who has been leading efforts on digital asset regulation, echoed his support for stablecoin legislation and stressed the need for broader clarity on digital assets. 
He also expressed hope that his separate crypto market structure bill, FIT21, could gain momentum by the end of the year, especially as his retirement in January looms.
With time running out for legislative action in Congress this year, pressure is mounting to finalize a stablecoin regulatory framework. 
The stakes are particularly high as the committee continues to discuss key digital asset issues, with all five commissioners of the U.S. Securities and Exchange Commission (SEC), including Chair Gary Gensler, testifying at the Tuesday hearing. 
Lawmakers grilled the commissioners on the SEC&#8217;s approach to digital assets, rulemaking, and oversight.
What&#8217;s Next: These discussions, along with the future of stablecoin regulation, will be central topics at the upcoming Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41007125/caitlin-long-says-progressives-are-actually-big-bank-corporatists-as-republican-lawmakers-">Caitlin Long Says &#8216;Progressives Are Actually Big-Bank Corporatists&#8217; As Republican Lawmakers Urge SEC To Repeal Crypto Accounting Rule</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Maxine Waters Says It's Time For 'A Grand Bargain' On Stablecoin Legislation Before Year's End

The ongoing threat of labor<a href="https://www.benzinga.com/news/24/09/40906726/us-port-strike-in-october-could-lead-to-major-supply-chain-disruptions-says-container-trade-expert"> strikes at U.S. ports</a>, typhoons in China and China&#8217;s upcoming seven-day National Golden Week holiday are set to disrupt the flow of containerized goods from China to the U.S., according to a container trade expert.
&#8220;Our regular surveys indicate that demand for U.S.-bound shipments from China remains strong, especially with Golden Week looming,&#8221; said Christian Roeloffs, CEO of Hamburg-based online container market platform Container xChange.
&#8220;Golden Week, starting Oct. 1, traditionally causes a temporary slowdown in logistics activities across China, with a noticeable dip lasting between seven and 10 days.&#8221;
&#8220;With these events in combination — the U.S. labor strikes, upcoming Golden Week, and port suspensions — the China-to-U.S. shipping route is set to be volatile and uncertain over the next 20 days,&#8221; Roeloffs added.
Chinese factories shut down during National Day Golden Week as its citizens celebrate the founding of the People&#8217;s Republic of China.
He noted that an anticipated strike by the International Longshoremen&#8217;s Association, which represents 85,000 dockworkers at 12 ports along the East and Gulf coasts, is prompting traders to accelerate their order schedules to avoid disruptions before the strike on Oct. 1.
Read Also: <a href="https://www.benzinga.com/government/24/09/40713418/retailers-plea-for-deal-us-ports-union-start-two-day-talk-in-effort-to-prevent-disruptive-strike">Retailers Plea For Deal: US Ports, Union Start Two-Day Talk In Effort To Prevent Disruptive Strike</a>
Last week, China faced its worst typhoon in 75 years, which made landfall on the east coast. According to container liner Hapag-Lloyd, the storm has caused delays of up to 60 hours at ports in Shanghai and up to 48 hours at ports in Ningbo. Another typhoon is also headed toward the region.
&#8220;This bottleneck is expected to worsen as Typhoon Pulasan approaches, potentially exacerbating the already strained situation,&#8221; Roeloffs said. &#8220;Several ports in Ningbo and Shanghai have announced the suspension of container operations.&#8221;
He added that these adverse conditions have not caused port congestion at Chinese ports due to trade volume declining in a tougher economic environment.
&#8220;At present, securing containers is not an issue, though this may change as market conditions evolve,&#8221; he said.
Price Action: A disruption of China&#8217;s exports to the U.S. will impact numerous sectors in the U.S. because they rely heavily on China for the products they need.
Retail, automotive, and semiconductor companies saw gains and losses in Tuesday&#8217;s early-afternoon trading.
Retail
<ul>
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) rose 0.35% to $80.61.</li>
<li>Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) declined 0.58% to $192.76.</li>
<li>Loews Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) slipped 0.32% to $78.42.</li>
</ul>
Automotive
<ul>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) fell 0.37% to $10.87.</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) declined 0.42% to $47.84.</li>
<li>Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) rose 0.55% to $15.53.</li>
</ul>
Semiconductors
<ul>
<li>Taiwan Semiconductor Manufacturing Co. Ltd. NYSE: TSM)  went up 3.42% to $180.74.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) rose 0.91% to $174.51.</li>
<li>Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) rose 1.14% to $167.85.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/08/40497103/strikes-at-us-ports-canadas-railways-may-cause-container-freight-rate-volatility">Strikes At US Ports, Canada&#8217;s Railways May Cause Container Freight Rate Volatility</a></li>
</ul>
Photo: ambient_pix/Shutterstock.com

Global

AMZN

AVGO

QCOM

STLA

China's Exports At Risk From Anticipated US Port Strikes, Typhoons, Golden Week, Warns Container Trade Expert

As Pennsylvania inches <a href="https://www.benzinga.com/markets/cannabis/24/09/40909516/pennsylvania-isnt-giving-up-on-recreational-cannabis-optimism-rises-as-lawmakers-reintroduce-gov">closer to legalizing</a> recreational cannabis, Philadelphia entrepreneurs and advocates are seizing the opportunity to ensure social equity in the emerging industry. <a href="https://www.blackcannabisweek.com/">Black Cannabis Week</a> is at the forefront of this movement, which launched in 2018 to educate Black and Latino communities about benefits and opportunities in the cannabis sector. 
Initially focused on <a href="https://www.benzinga.com/topic/medical-cannabis">medical marijuana</a>, the event has evolved to discuss the potential of <a href="https://www.benzinga.com/topic/recreational-cannabis">adult-use cannabis</a> legalization in Pennsylvania as well as demands for <a href="https://www.benzinga.com/topic/social-equity">equitable legislation and social justice</a> reforms.
"We are demanding social justice, demanding equitable legislation, which is something we did not have for our medical marijuana program," said Cherron Perry-Thomas, co-founder of Black Cannabis Week, <a href="https://whyy.org/articles/black-cannabis-week-philadelphia-entrepeneurs-social-justice-recreational-marijuana/">reported</a> the local NPR station WHYY. The event seeks to empower local entrepreneurs, particularly those from communities disproportionately impacted by past marijuana laws, and to help them prepare for the potential opportunities in a legalized adult-use market.
<h3 class="wp-block-heading">Empowering Communities Through Education And Advocacy</h3>
The week-long event features a range of activities, including policy discussions, job fairs, a film festival, even a fashion show with the focus is on making the cannabis industry more inclusive. Kristal Bush, a lead organizer, emphasized that the format is more interactive than traditional conferences, with events designed to engage and educate attendees in innovative ways.
The push for social equity in cannabis goes beyond just creating opportunities for new businesses. Organizers are also advocating for legal reforms to help individuals with prior marijuana convictions, who are often excluded from the industry. "We think this is a civil rights issue," Perry-Thomas explained, adding that the industry's growth could offer one of the last chances for communities harmed by the War on Drugs to gain justice and economic empowerment.
<h3 class="wp-block-heading">Potential Of Pennsylvania&#8217;s Adult-Use Market</h3>
According to <a href="http://www.ifo.state.pa.us/download.cfm?file=Resources/Documents/Revenue_Proposal_Analysis_2024_03.pdf">estimates</a> from the Pennsylvania Independent Fiscal Office, if adult-use cannabis is legalized in PA, the state could generate between $400 million and $1 billion in tax revenue. However, advocates argue that without equitable laws in place, much of this wealth could bypass communities of color, who were disproportionately affected by past marijuana criminalization. Organizers of Black Cannabis Week are working to ensure that this doesn't happen, advocating for laws that support local, minority-owned businesses and expungement programs for past marijuana convictions.
Cover image made with AI

Cannabis

Regulations

Politics

Black Cannabis Week: Philly Entrepreneurs Ignite Social Justice Movement Around PA's Marijuana Laws

Chief District Judge Thomas Kleeh <a href="https://www.courtlistener.com/docket/68435952/in-re-aflibercept-patent-litigation/?filed_after=&amp;filed_before=&amp;entry_gte=&amp;entry_lte=&amp;order_by=desc#entry-343">denied</a> Regeneron Pharmaceuticals, Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) effort to prevent the sale of Amgen Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) Eylea biosimilar.
Regeneron filed a notice of its appeal to the U.S. Court of Appeals for the Federal Circuit.
The <a target="_blank" href="https://www.bloomberglaw.com/public/desktop/document/InReAfliberceptPatentLitigationDocketNo124md03103NDWVaApr112024Co/9?doc_id=X5Q74042K7G9TGAR2GDOLU0DNF6" rel="noreferrer noopener">appeal </a>is from the Order issued on September 23, 2024, which denied Regeneron&#8217;s request for a preliminary injunction, along with any related orders, decisions, rulings, findings, or conclusions connected to that Order.
Reuters highlighted that an Amgen spokesperson expressed the company&#8217;s satisfaction with the decision. Amgen will reveal the timeline for launching its biosimilar Pavblu &#8220;in due course.&#8221;
Regeneron sued Amgen in January, alleging that it was developing a biosimilar that violated key patent protections for Eylea. The lawsuit claims the infringement of over 30 patents, which the pharma claims will &#8220;irreparably&#8221; harm its business if Amgen is not &#8220;enjoined&#8221; from violating these protections.
The lawsuit also <a target="_blank" href="https://fingfx.thomsonreuters.com/gfx/legaldocs/egpbakxeavq/REGENERON%20AMGEN%20LAWSUIT%20complaint.pdf" rel="noreferrer noopener">notes</a>, &#8220;Amgen&#8217;s commercial manufacture, use, offer for sale, and/or sale within the United States, or importation into the United States, of ABP 938 before the expiration of the '106 patent will cause Regeneron injury, entitling Regeneron to damages and/or other monetary relief.&#8221;
In October 2023, Amgen said the FDA <a target="_blank" href="https://investors.amgen.com/news-releases/news-release-details/amgen-reports-third-quarter-financial-results" rel="noreferrer noopener">accepted</a> its abbreviated Biologics Drug Application for ABP 938, a biosimilar copy of Eylea.
Stat News <a target="_blank" href="https://www.statnews.com/2024/09/24/regeneron-eylea-biosimilar-amgen-fight-heats-up/" rel="noreferrer noopener">noted</a> that the judge&#8217;s decision came as a surprise, given that this same judge had previously approved Regeneron&#8217;s requests for injunctions against other pharmaceutical companies attempting to release Eylea biosimilars.
In December, a court ruling found that Viatris Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>) replica of Regeneron&#8217;s Eylea <a href="https://www.benzinga.com/general/biotech/23/12/36408741/regeneron-celebrates-legal-win-court-upholds-eylea-medication-patent" target="_blank" rel="noreferrer noopener">violated patent rights</a>.
Price Action: REGN stock is down 6% at $1,025.44 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41010674/diamondback-energy-kinetik-strengthen-stake-in-epic-crude-with-new-deal-and-long-term-commitment" target="_blank" rel="noreferrer noopener">Diamondback Energy, Kinetik Strengthen Stake In EPIC Crude With New Deal And Long-Term Commitments</a>.</li>
</ul>

Biotech

Legal

Movers

General

AMGN

REGN

VTRS

Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?

In a recent interview with Anthony Scaramucci, crypto analyst Noelle Acheson offered insights on the interplay between macroeconomics and cryptocurrency, highlighting Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) potential as a hedge <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39866338/bitcoin-as-a-strategic-reserve-asset-for-the-us-expert-details-how-trump-could-make-it-hap">against economic instability</a>.
What Happened: In an <a href="https://www.youtube.com/watch?v=i5iKqs26Mkg&amp;t=871s">episode</a> of Wealthion, Acheson views Bitcoin and gold as safeguards against currency debasement and political turmoil. 
She emphasized to Scaramucci, who will be a headline speaker at Benzinga's upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19,  that currency debasement leads to widening inequality, which leads to greater polarization. 
Acheson stated that despite all the political instability, gold has still managed to peak at all-time highs. This sends a message to investors that bitcoin has still not reached its peak and can do so but currently remains impacted by legal irregularities, and political concerns in the crypto sector.
She suggests that bitcoin and gold remain the two best options for investments in such an environment.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
On Bitcoin&#8217;s future price, Acheson remained cautiously optimistic, noting that a rise to $100,000 by year-end is "not out of the question," though she stressed the difficulty of precise predictions. She said that for this prediction, it will have to move higher by 0.45% daily.
She links the price prediction to the supply factor, comparing it to gold whose scarcity in supply can be met by alternate methods of production if prices reach $100,000. However, this is not the case with Bitcoin.
Looking ahead, Acheson expressed concerns about a potential economic slowdown, warning, "This is heading into that dreaded word stagflation which is not off the table for next year."
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40858231/bitcoin-decouples-from-gold-investors-leaning-towards-traditional-safe-haven-assets-crypto">Bitcoin Decouples From Gold: &#8216;Investors Leaning Towards Traditional Safe-Haven Assets,&#8217; CryptoQuant Signals</a></li>
</ul>
Image: Shutterstock

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Plover Bay Technologies

News

Latest news for Plover Bay Technologies (OTC:PBTDF) Stock